Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 419539, 18 pages
http://dx.doi.org/10.1155/2009/419539
Review Article

Silencing Viral MicroRNA as a Novel Antiviral Therapy?

Department of Microbiology and Virology, University of Tromsø, N-9037 Tromsø, Norway

Received 28 December 2008; Accepted 20 March 2009

Academic Editor: Bibekanand Mallick

Copyright © 2009 Ugo Moens. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. zur Hausen, “Papillomaviruses and cancer: from basic studies to clinical application,” Nature Reviews Cancer, vol. 2, no. 5, pp. 342–350, 2002. View at Publisher · View at Google Scholar · View at PubMed
  2. L. Coscoy, “Immune evasion by Kaposi's sarcoma-associated herpesvirus,” Nature Reviews Immunology, vol. 7, no. 5, pp. 391–401, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. B. Damania, “DNA tumor viruses and human cancer,” Trends in Microbiology, vol. 15, no. 1, pp. 38–44, 2007. View at Publisher · View at Google Scholar · View at PubMed
  4. E. Klein, L. L. Kis, and G. Klein, “Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions,” Oncogene, vol. 26, no. 9, pp. 1297–1305, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. M. Matsuoka and K.-T. Jeang, “Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation,” Nature Reviews Cancer, vol. 7, no. 4, pp. 270–280, 2007. View at Publisher · View at Google Scholar · View at PubMed
  6. V. E. Gurtsevitch, “Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis,” Biochemistry, vol. 73, no. 5, pp. 504–513, 2008. View at Publisher · View at Google Scholar
  7. U. Moens and M. Johannessen, “Human polyomaviruses and cancer: expanding repertoire,” Journal of the German Society of Dermatology, vol. 6, no. 9, pp. 704–708, 2008. View at Publisher · View at Google Scholar · View at PubMed
  8. V. Brower, “Connecting viruses to cancer: how research moves from association to causation,” Journal of the National Cancer Institute, vol. 96, no. 4, pp. 256–257, 2004. View at Google Scholar
  9. D. M. Morens, G. K. Folkers, and A. S. Fauci, “The challenge of emerging and re-emerging infectious diseases,” Nature, vol. 430, no. 6996, pp. 242–249, 2004. View at Publisher · View at Google Scholar · View at PubMed
  10. World Health Organization, 2008, http://www.who.int/healthinfo/morttables/en/index.html.
  11. B. R. Cullen, “Viruses and microRNAs,” Nature Genetics, vol. 38, pp. S25–S30, 2006. View at Publisher · View at Google Scholar · View at PubMed
  12. B. Berkhout and J. Haasnoot, “The interplay between virus infection and the cellular RNA interference machinery,” FEBS Letters, vol. 580, no. 12, pp. 2896–2902, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. B. Berkhout and K.-T. Jeang, “RISCy business: microRNAs, pathogenesis, and viruses,” Journal of Biological Chemistry, vol. 282, no. 37, pp. 26641–26645, 2007. View at Publisher · View at Google Scholar · View at PubMed
  14. J. Haasnoot, E. M. Westerhout, and B. Berkhout, “RNA interference against viruses: strike and counterstrike,” Nature Biotechnology, vol. 25, no. 12, pp. 1435–1443, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. W. de Vries and B. Berkhout, “RNAi suppressors encoded by pathogenic human viruses,” International Journal of Biochemistry & Cell Biology, vol. 40, no. 10, pp. 2007–2012, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. B. R. Cullen, “Viral and cellular messenger RNA targets of viral microRNAs,” Nature, vol. 457, no. 7228, pp. 421–425, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. Z. Ghosh, B. Mallick, and J. Chakrabarti, “Cellular versus viral microRNAs in host-virus interaction,” Nucleic Acid Research, vol. 37, no. 4, pp. 1035–1048, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. M. N. Poy, M. Spranger, and M. Stoffel, “MicroRNAs and the regulation of glucose and lipid metabolism,” Diabetes, Obesity and Metabolism, vol. 9, pp. 67–73, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. Y. Zhao and D. Srivastava, “A developmental view of microRNA function,” Trends in Biochemical Sciences, vol. 32, no. 4, pp. 189–197, 2007. View at Publisher · View at Google Scholar · View at PubMed
  20. D. Baltimore, M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov, “MicroRNAs: new regulators of immune cell development and function,” Nature Immunology, vol. 9, no. 8, pp. 839–845, 2008. View at Publisher · View at Google Scholar · View at PubMed
  21. F.-B. Gao, “Posttranscriptional control of neuronal development by microRNA networks,” Trends in Neurosciences, vol. 31, no. 1, pp. 20–26, 2008. View at Publisher · View at Google Scholar · View at PubMed
  22. S. Griffiths-Jones, H. K. Saini, S. van Dongen, and A. J. Enright, “miRBase: tools for microRNA genomics,” Nucleic Acids Research, vol. 36, database issue, pp. D154–D158, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at PubMed
  24. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar
  25. E. Gottwein and B. R. Cullen, “Viral and cellular microRNAs as determinants of viral pathogenesis and immunity,” Cell Host & Microbe, vol. 3, no. 6, pp. 375–387, 2008. View at Publisher · View at Google Scholar · View at PubMed
  26. J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, “Principles of microRNA-target recognition,” PLoS Biology, vol. 3, no. 3, article e85, pp. 1–15, 2005. View at Publisher · View at Google Scholar · View at PubMed
  27. A. Krek, D. Grün, M. N. Poy et al., “Combinatorial microRNA target predictions,” Nature Genetics, vol. 37, no. 5, pp. 495–500, 2005. View at Publisher · View at Google Scholar · View at PubMed
  28. J. Mattes, A. Collison, and P. S. Foster, “Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation,” Current Opinion in Molecular Therapeutics, vol. 10, no. 2, pp. 150–157, 2008. View at Google Scholar
  29. C. C. Esau, “Inhibition of microRNA with antisense oligonucleotides,” Methods, vol. 44, no. 1, pp. 55–60, 2008. View at Publisher · View at Google Scholar · View at PubMed
  30. J. Elmén, M. Lindow, S. Schütz et al., “LNA-mediated microRNA silencing in non-human primates,” Nature, vol. 452, no. 7189, pp. 896–899, 2008. View at Publisher · View at Google Scholar · View at PubMed
  31. K. B. Spurgers, C. M. Sharkey, K. L. Warfield, and S. Bavari, “Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses,” Antiviral Research, vol. 78, no. 1, pp. 26–36, 2008. View at Publisher · View at Google Scholar · View at PubMed
  32. J. Krützfeldt, N. Rajewsky, R. Braich et al., “Silencing of microRNAs in vivo with ‘antagomirs’,” Nature, vol. 438, no. 7068, pp. 685–689, 2005. View at Publisher · View at Google Scholar · View at PubMed
  33. J. Krützfeldt, S. Kuwajima, R. Braich et al., “Specificity, duplex degradation and subcellular localization of antagomirs,” Nucleic Acids Research, vol. 35, no. 9, pp. 2885–2892, 2007. View at Publisher · View at Google Scholar · View at PubMed
  34. J. Mattes, M. Yang, and P. S. Foster, “Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function?,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 1, pp. 8–12, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. C. Esau, S. Davis, S. F. Murray et al., “miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting,” Cell Metabolism, vol. 3, no. 2, pp. 87–98, 2006. View at Publisher · View at Google Scholar · View at PubMed
  36. M. Egholm, O. Buchardt, L. Christensen et al., “PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules,” Nature, vol. 365, no. 6446, pp. 566–568, 1993. View at Publisher · View at Google Scholar · View at PubMed
  37. M. M. Fabani and M. J. Gait, “miR-122 targeting with LNA/2-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates,” RNA, vol. 14, no. 2, pp. 336–346, 2008. View at Publisher · View at Google Scholar · View at PubMed
  38. J. Weiler, J. Hunziker, and J. Hall, “Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?,” Gene Therapy, vol. 13, no. 6, pp. 496–502, 2006. View at Publisher · View at Google Scholar · View at PubMed
  39. U. Moens, M. Van Ghelue, and M. Johannessen, “Human polyomaviruses: molecular mechanisms for transformation and their association with cancers,” in New Research on Oncogenic Viruses, E. I. Tuneley, Ed., pp. 1–63, Nova Science, New York, NY, USA, 2008. View at Google Scholar
  40. M. Jiang, J. R. Abend, S. F. Johnson, and M. J. Imperiale, “The role of polyomaviruses in human disease,” Virology, vol. 384, no. 2, pp. 266–273, 2009. View at Publisher · View at Google Scholar · View at PubMed
  41. T. Allander, K. Andreasson, S. Gupta et al., “Identification of a third human polyomavirus,” Journal of Virology, vol. 81, no. 8, pp. 4130–4136, 2007. View at Publisher · View at Google Scholar · View at PubMed
  42. A. M. Gaynor, M. D. Nissen, D. M. Whiley et al., “Identification of a novel polyomavirus from patients with acute respiratory tract infections,” PLoS Pathogens, vol. 3, no. 5, article e64, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at PubMed
  43. H. Feng, M. Shuda, Y. Chang, and P. S. Moore, “Clonal integration of a polyomavirus in human Merkel cell carcinoma,” Science, vol. 319, no. 5866, pp. 1096–1100, 2008. View at Publisher · View at Google Scholar · View at PubMed
  44. U. Moens and O. P. Rekvig, “Molecular biology of BK virus and clinical aspects of BK virus renal infection,” in Human Polyomaviruses: Molecular and Clinical Perspectives, K. Khalili and G. L. Stoner, Eds., pp. 359–408, Wiley Liss, New York, NY, USA, 2001. View at Google Scholar
  45. C. S. Sullivan, A. T. Grundhoff, S. Tevethia, J. M. Pipas, and D. Ganem, “SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells,” Nature, vol. 435, no. 7042, pp. 682–686, 2005. View at Publisher · View at Google Scholar · View at PubMed
  46. G. J. Seo, L. H. L. Fink, B. O'Hara, W. J. Atwood, and C. S. Sullivan, “Evolutionarily conserved function of a viral microRNA,” Journal of Virology, vol. 82, no. 20, pp. 9823–9828, 2008. View at Publisher · View at Google Scholar · View at PubMed
  47. G. J. Seo, C. J. Chen, and C. S. Sullivan, “Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression,” Virology, vol. 383, no. 2, pp. 183–187, 2009. View at Publisher · View at Google Scholar · View at PubMed
  48. J. L. Umbach, M. F. Kramer, I. Jurak, H. W. Karnowski, D. M. Coen, and B. R. Cullen, “MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs,” Nature, vol. 454, no. 7205, pp. 780–783, 2008. View at Publisher · View at Google Scholar · View at PubMed
  49. W. Dunn, P. Trang, Q. Zhong, E. Yang, C. van Belle, and F. Liu, “Human cytomegalovirus expresses novel microRNAs during productive viral infection,” Cellular Microbiology, vol. 7, no. 11, pp. 1684–1695, 2005. View at Publisher · View at Google Scholar · View at PubMed
  50. F. Grey and J. Nelson, “Identification and function of human cytomegalovirus microRNAs,” Journal of Clinical Virology, vol. 41, no. 3, pp. 186–191, 2008. View at Publisher · View at Google Scholar · View at PubMed
  51. S. Pfeffer, M. Zavolan, F. A. Grässer et al., “Identification of virus-encoded microRNAs,” Science, vol. 304, no. 5671, pp. 734–736, 2004. View at Publisher · View at Google Scholar · View at PubMed
  52. L. He, J. M. Thomson, M. T. Hemann et al., “A microRNA polycistron as a potential human oncogene,” Nature, vol. 435, no. 7043, pp. 828–833, 2005. View at Publisher · View at Google Scholar · View at PubMed
  53. C. Seeger, F. Zoulin, and W. S. Mason, “Hepadnaviruses,” in Fields’ Virology, D. M. Knipe and P. M. Howeley, Eds., pp. 2847–2888, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  54. W.-B. Jin, F.-L. Wu, D. Kong, and A.-G. Guo, “HBV-encoded microRNA candidate and its target,” Computational Biology and Chemistry, vol. 31, no. 2, pp. 124–126, 2007. View at Publisher · View at Google Scholar · View at PubMed
  55. M. A. Wainberg and K.-T. Jeang, “25 years of HIV-1 research—progress and perspectives,” BMC Medicine, vol. 6, article 31, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at PubMed
  56. L. B. Ludwig, “RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus,” Retrovirology, vol. 5, article 79, pp. 1–13, 2008. View at Publisher · View at Google Scholar · View at PubMed
  57. S. Omoto, M. Ito, Y. Tsutsumi et al., “HIV-1 nef suppression by virally encoded microRNA,” Retrovirology, vol. 1, p. 44, 2004. View at Google Scholar
  58. X. Cai, G. Li, L. A. Laimins, and B. R. Cullen, “Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication,” Journal of Virology, vol. 80, no. 21, pp. 10890–10893, 2006. View at Publisher · View at Google Scholar · View at PubMed
  59. W. S. M. Wold and M. S. Horowitz, “Adenoviruses,” in Fields' Virology, D. M. Knipe and P. M. Howeley, Eds., pp. 2395–2436, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  60. M. B. Mathews, “Structure, function and evolution of adenovirus virus-associated RNAs,” Current Topics in Microbiology and Immunology, vol. 199, part 2, pp. 173–187, 1995. View at Google Scholar
  61. M. G. Andersson, P. C. J. Haasnoot, N. Xu, S. Berenjian, B. Berkhout, and G. Akusjärvi, “Suppression of RNA interference by adenovirus virus-associated RNA,” Journal of Virology, vol. 79, no. 15, pp. 9556–9565, 2005. View at Publisher · View at Google Scholar · View at PubMed
  62. O. Aparicio, N. Razquin, M. Zaratiegui, I. Narvaiza, and P. Fortes, “Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production,” Journal of Virology, vol. 80, no. 3, pp. 1376–1384, 2006. View at Publisher · View at Google Scholar · View at PubMed
  63. M. Sano, Y. Kato, and K. Taira, “Sequence-specific interference by small RNAs derived from adenovirus VAI RNA,” FEBS Letters, vol. 580, no. 6, pp. 1553–1564, 2006. View at Publisher · View at Google Scholar · View at PubMed
  64. P. E. Pellet and B. Roizman, “The family Herpesviridae: a brief introduction,” in Fields' Virology, D. M. Knipe and P. M. Howeley, Eds., pp. 2479–2500, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  65. S. Pfeffer, A. Sewer, M. Lagos-Quintana et al., “Identification of microRNAs of the herpesvirus family,” Nature Methods, vol. 2, no. 4, pp. 269–276, 2005. View at Publisher · View at Google Scholar · View at PubMed
  66. X. Cai, A. Schäfer, S. Lu et al., “Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed,” PLoS Pathogens, vol. 2, no. 3, article e23, pp. 1–12, 2006. View at Publisher · View at Google Scholar · View at PubMed
  67. A. Gupta, J. J. Gartner, P. Sethupathy, A. G. Hatzigeorgiou, and N. W. Fraser, “Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript,” Nature, vol. 442, no. 7098, pp. 82–85, 2006. View at Publisher · View at Google Scholar · View at PubMed
  68. S. Tang, A. S. Bertke, A. Patel, K. Wang, J. I. Cohen, and P. R. Krause, “An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 31, pp. 10931–10936, 2008. View at Publisher · View at Google Scholar · View at PubMed
  69. C. Cui, A. Griffiths, G. Li et al., “Prediction and identification of herpes simplex virus 1-encoded microRNAs,” Journal of Virology, vol. 80, no. 11, pp. 5499–5508, 2006. View at Publisher · View at Google Scholar · View at PubMed
  70. S. Tang, A. Patel, and P. R. Krause, “Novel less-abundant viral miRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs,” Journal of Virology, vol. 83, no. 3, pp. 1433–1442, 2009. View at Publisher · View at Google Scholar · View at PubMed
  71. R. Grassmann and K.-T. Jeang, “The roles of microRNAs in mammalian virus infection,” Biochimica et Biophysica Acta, vol. 1779, no. 11, pp. 706–711, 2008. View at Publisher · View at Google Scholar · View at PubMed
  72. N. Stern-Ginossar, N. Elefant, A. Zimmermann et al., “Host immune system gene targeting by a viral miRNA,” Science, vol. 317, no. 5836, pp. 376–381, 2007. View at Publisher · View at Google Scholar · View at PubMed
  73. E. Murphy, J. Vaníček, H. Robins, T. Shenk, and A. J. Levine, “Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 14, pp. 5453–5458, 2008. View at Publisher · View at Google Scholar · View at PubMed
  74. F. Grey, H. Meyers, E. A. White, D. H. Spector, and J. Nelson, “A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication,” PloS Pathogens, vol. 3, article e163, no. 11, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at PubMed
  75. A. Grundhoff, C. S. Sullivan, and D. Ganem, “A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses,” RNA, vol. 12, no. 5, pp. 733–750, 2006. View at Publisher · View at Google Scholar · View at PubMed
  76. A. K. F. Lo, K. F. To, K. W. Lo et al., “Modulation of LMP1 protein expression by EBV-encoded microRNAs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16164–16169, 2007. View at Publisher · View at Google Scholar · View at PubMed
  77. S. Barth, T. Pfuhl, A. Mamiani et al., “Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5,” Nucleic Acids Research, vol. 36, no. 2, pp. 666–675, 2008. View at Publisher · View at Google Scholar · View at PubMed
  78. E. Y. Choy, K. L. Siu, K. H. Kok et al., “An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival,” The Journal of Experimental Medicine, vol. 205, no. 11, pp. 2551–2560, 2008. View at Publisher · View at Google Scholar · View at PubMed
  79. T. Xia, A. O'Hara, I. Araujo et al., “EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3,” Cancer Research, vol. 68, no. 5, pp. 1436–1442, 2008. View at Publisher · View at Google Scholar · View at PubMed
  80. M. A. Samols, R. L. Skalsky, A. M. Maldonado et al., “Identification of cellular genes targeted by KSHV-encoded microRNA,” PLoS Pathogens, vol. 3, no. 5, article e65, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at PubMed
  81. E. Gottwein, N. Mukherjee, C. Sachse et al., “A viral microRNA functions as an orthologue of cellular miR-155,” Nature, vol. 450, no. 7172, pp. 1096–1099, 2007. View at Publisher · View at Google Scholar · View at PubMed
  82. R. L. Skalsky, M. A. Samols, K. B. Plaisance et al., “Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155,” Journal of Virology, vol. 81, no. 23, pp. 12836–12845, 2007. View at Publisher · View at Google Scholar · View at PubMed
  83. Z. Klase, P. Kale, R. Winograd et al., “HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR,” BMC Molecular Biology, vol. 8, article 63, pp. 1–19, 2007. View at Publisher · View at Google Scholar · View at PubMed
  84. D. L. Ouellet, I. Plante, P. Landry et al., “Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element,” Nucleic Acids Research, vol. 36, no. 7, pp. 2353–2365, 2008. View at Publisher · View at Google Scholar · View at PubMed
  85. Y. Bennasser, S.-Y. Le, M. L. Yeung, and K.-T. Jeang, “HIV-1 encoded candidate micro-RNAs and their cellular targets,” Retrovirology, vol. 1, article 43, pp. 1–5, 2004. View at Publisher · View at Google Scholar · View at PubMed
  86. J. L. Foster and J. V. Garcia, “HIV-1 Nef: at the crossroads,” Retrovirology, vol. 5, article 84, pp. 1–13, 2008. View at Publisher · View at Google Scholar · View at PubMed
  87. K. J. Purzycka and R. W. Adamiak, “The HIV-2 TAR RNA domain as a potential source of viral-encoded miRNA. A reconnaissance study,” Nucleic Acids Symposium Series, vol. 52, no. 1, pp. 511–512, 2008. View at Publisher · View at Google Scholar · View at PubMed
  88. J. Lin and B. R. Cullen, “Analysis of the interaction of primate retroviruses with the human RNA interference machinery,” Journal of Virology, vol. 81, no. 22, pp. 12218–12226, 2007. View at Publisher · View at Google Scholar · View at PubMed
  89. B. Roizman, D. M. Knipe, and R. J. Whitley, “Herpes simplex viruses,” in Fields' Virology, D. M. Knipe and P. M. Howeley, Eds., pp. 2501–2602, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  90. B. Sugden, “Virology: micro mystery solution,” Nature, vol. 442, no. 7098, pp. 33–34, 2006. View at Publisher · View at Google Scholar · View at PubMed
  91. A. Gupta, J. J. Gartner, P. Sethupathy, A. G. Hatzigeorgiou, and N. W. Fraser, “Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript,” Nature, vol. 451, no. 7178, p. 600, 2008. View at Publisher · View at Google Scholar · View at PubMed
  92. R. Gupta, T. Warren, and A. Wald, “Genital herpes,” The Lancet, vol. 370, no. 9605, pp. 2127–2137, 2007. View at Publisher · View at Google Scholar · View at PubMed
  93. A. Orvedahl, D. Alexander, Z. Tallóczy et al., “HSV-1 ICP34.5 confers neurovirulence by targeting the beclin 1 autophagy protein,” Cell Host & Microbe, vol. 1, no. 1, pp. 23–35, 2007. View at Publisher · View at Google Scholar · View at PubMed
  94. J. I. Cohen, S. E. Straus, and A. M. Arvin, “Varicella-zoster virus,” in Fields' Virology, D. M. Knipe and P. M. Howeley, Eds., pp. 2733–2818, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  95. F. Grey, L. Hook, and J. Nelson, “The functions of herpesvirus-encoded microRNAs,” Medical Microbiology and Immunology, vol. 197, no. 2, pp. 261–267, 2008. View at Publisher · View at Google Scholar · View at PubMed
  96. J. A. Nelson, “Small RNAs and large DNA viruses,” The New England Journal of Medicine, vol. 357, no. 25, pp. 2630–2632, 2007. View at Publisher · View at Google Scholar · View at PubMed
  97. L. S. Young and A. B. Rickinson, “Epstein-Barr virus: 40 years on,” Nature Reviews Cancer, vol. 4, no. 10, pp. 757–768, 2004. View at Publisher · View at Google Scholar · View at PubMed
  98. L. Xing and E. Kieff, “Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication,” Journal of Virology, vol. 81, no. 18, pp. 9967–9975, 2007. View at Publisher · View at Google Scholar · View at PubMed
  99. D. N. Kim, H.-S. Chae, S. T. Oh et al., “Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma,” Journal of Virology, vol. 81, no. 2, pp. 1033–1036, 2007. View at Publisher · View at Google Scholar · View at PubMed
  100. R. H. Edwards, A. R. Marquitz, and N. Raab-Traub, “Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing,” Journal of Virology, vol. 82, no. 18, pp. 9094–9106, 2008. View at Publisher · View at Google Scholar · View at PubMed
  101. M. M. Brinkmann and T. F. Schulz, “Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae,” Journal of General Virology, vol. 87, no. 5, pp. 1047–1074, 2006. View at Publisher · View at Google Scholar · View at PubMed
  102. U. Moens and M. Johannessen, “Mechanisms by which viral proteins of human DNA tumor viruses hijack the cell cycle,” in DNA Tumor Viruses, H. E. Tao, Ed., pp. 1–48, Nova Science, New York, NY, USA, 2008. View at Google Scholar
  103. P. Sethupathy, M. Megraw, and A. G. Hatzigeorgiou, “A guide through present computational approaches for the identification of mammalian microRNA targets,” Nature Methods, vol. 3, no. 11, pp. 881–886, 2006. View at Publisher · View at Google Scholar · View at PubMed
  104. X. Yang, Y. Chu, Y. Wang, Q. Guo, and S. Xiong, “Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells,” Vaccine, vol. 24, no. 15, pp. 2966–2974, 2006. View at Publisher · View at Google Scholar · View at PubMed
  105. P. J. Hensbergen, P. G. Wijnands, M. W. J. Schreurs, R. J. Scheper, R. Willemze, and C. P. Tensen, “The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis,” Journal of Immunotherapy, vol. 28, no. 4, pp. 343–351, 2005. View at Publisher · View at Google Scholar
  106. D. Ganem, “Kaposi's sarcoma-associated virus,” in Fields' Virology, D. M. Knipe and P. M. Howeley, Eds., pp. 2847–2888, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2007. View at Google Scholar
  107. V. Marshall, T. Parks, R. Bagni et al., “Conservation of viraly encoded microRNAs in Kaposi sarcoma-associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease,” The Journal of Infectious Diseases, vol. 195, no. 5, pp. 645–659, 2007. View at Publisher · View at Google Scholar · View at PubMed
  108. D. Ganem and J. Ziegelbauer, “MicroRNAs of Kaposi's sarcoma-associated herpes virus,” Seminars in Cancer Biology, vol. 18, no. 6, pp. 437–440, 2008. View at Publisher · View at Google Scholar · View at PubMed
  109. J. M. Ziegelbauer, C. S. Sullivan, and D. Ganem, “Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs,” Nature Genetics, vol. 41, no. 1, pp. 130–134, 2009. View at Publisher · View at Google Scholar · View at PubMed
  110. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at PubMed
  111. S. Costinean, N. Zanesi, Y. Pekarsky et al., “Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7024–7029, 2006. View at Publisher · View at Google Scholar · View at PubMed
  112. J. Sun, M. Brand, Y. Zenke, S. Tashiro, M. Groudine, and K. Igarashi, “Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 6, pp. 1461–1466, 2004. View at Publisher · View at Google Scholar · View at PubMed
  113. E. Shaulian and M. Karin, “AP-1 as a regulator of cell life and death,” Nature Cell Biology, vol. 4, no. 5, pp. E131–E136, 2002. View at Publisher · View at Google Scholar · View at PubMed
  114. A. Cimmino, G. A. Calin, M. Fabbri et al., “miR-15 and miR-16 induce apoptosis by targeting BCL2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13944–13949, 2005. View at Publisher · View at Google Scholar · View at PubMed
  115. M. S. Weinberg and K. V. Morris, “Are viral-encoded microRNAs mediating latent HIV-1 infection?,” DNA and Cell Biology, vol. 25, no. 4, pp. 223–231, 2006. View at Publisher · View at Google Scholar · View at PubMed
  116. M. Barboric and B. M. Peterlin, “A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation,” PLoS Biology, vol. 3, no. 2, article e76, pp. 200–203, 2005. View at Publisher · View at Google Scholar · View at PubMed
  117. L. B. Ludwig, J. L. Ambrus, Jr., K. A. Krawczyk et al., “Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products,” Retrovirology, vol. 3, article 80, pp. 1–20, 2006. View at Publisher · View at Google Scholar · View at PubMed
  118. S. Omoto and Y. R. Fujii, “Regulation of human immunodeficiency virus 1 transcription by nef microRNA,” Journal of General Virology, vol. 86, no. 3, pp. 751–755, 2005. View at Publisher · View at Google Scholar · View at PubMed
  119. J. P. Couturier and R. S. Root-Bernstein, “HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins,” Journal of Theoretical Biology, vol. 235, no. 2, pp. 169–184, 2005. View at Publisher · View at Google Scholar · View at PubMed
  120. C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow, “Molecular biology: modulation of hepatitis C virus RNA abundance by a liver-specific microRNA,” Science, vol. 309, no. 5740, pp. 1577–1581, 2005. View at Publisher · View at Google Scholar · View at PubMed
  121. G. Randall, M. Panis, J. D. Cooper et al., “Cellular cofactors affecting hepatitis C virus infection and replication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 31, pp. 12884–12889, 2007. View at Publisher · View at Google Scholar · View at PubMed
  122. J. Anderson, C. Schiffer, S. K. Lee, and R. Swanstrom, “Viral protease inhibitors,” Handbook of Experimental Pharmacology, vol. 189, pp. 85–110, 2009. View at Google Scholar
  123. E. De Clercq and J. Neyts, “Antiviral agents acting as DNA or RNA chain terminators,” Handbook of Experimental Pharmacology, vol. 189, pp. 53–84, 2009. View at Google Scholar
  124. P. Kumar, H.-S. Ban, S.-S. Kim et al., “T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice,” Cell, vol. 134, no. 4, pp. 577–586, 2008. View at Publisher · View at Google Scholar · View at PubMed
  125. C. Rauschhuber, H. Xu, F. H. Salazar, P. L. Marion, and A. Ehrhardt, “Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice,” The Journal of Gene Medicine, vol. 10, no. 8, pp. 878–889, 2008. View at Publisher · View at Google Scholar · View at PubMed
  126. F. Eckstein, “The versatility of oligonucleotides as potential therapeutics,” Expert Opinion on Biological Therapy, vol. 7, no. 7, pp. 1021–1034, 2007. View at Publisher · View at Google Scholar · View at PubMed
  127. D. H. Le, “RNA-interference therapy for HBV infection enters Phase I clinical trial,” Expert Review of Anti-Infective Therapy, vol. 6, no. 1, pp. 5–8, 2008. View at Publisher · View at Google Scholar
  128. E. M. Westerhout, M. Ooms, M. Vink, A. T. Das, and B. Berkhout, “HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome,” Nucleic Acids Research, vol. 33, no. 2, pp. 796–804, 2005. View at Publisher · View at Google Scholar · View at PubMed
  129. D. Boden, O. Pusch, and B. Ramratnam, “Overcoming HIV-1 resistance to RNA interference,” Frontiers in Bioscience, vol. 12, pp. 3104–3116, 2007. View at Publisher · View at Google Scholar
  130. S. He, Z. Yang, G. Skogerbo et al., “The properties and functions of virus encoded microRNA, siRNA, and other small noncoding RNAs,” Critical Reviews in Microbiology, vol. 34, no. 3-4, pp. 175–188, 2008. View at Publisher · View at Google Scholar · View at PubMed
  131. N. Blow, “Small RNAs: delivering the future,” Nature, vol. 450, no. 7172, pp. 1117–1120, 2007. View at Publisher · View at Google Scholar · View at PubMed
  132. M. Scherr, L. Venturini, K. Battmer et al., “Lentivirus-mediated antagomir expression for specific inhibition of miRNA function,” Nucleic Acids Research, vol. 35, no. 22, article e149, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at PubMed
  133. E. R. Rayburn and R. Zhang, “Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?,” Drug Discovery Today, vol. 13, no. 11-12, pp. 513–521, 2008. View at Publisher · View at Google Scholar · View at PubMed
  134. L. L. Snyder, J. M. Esser, C. J. Pachuk, and L. F. Steel, “Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts,” Antiviral Research, vol. 80, no. 1, pp. 36–44, 2008. View at Publisher · View at Google Scholar · View at PubMed
  135. M. Dimitrova, C. Affolter, F. Meyer et al., “Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 42, pp. 16320–16325, 2008. View at Publisher · View at Google Scholar · View at PubMed
  136. Y.-J. Zhang, K.-Y. Wang, D. A. Stein et al., “Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers,” Antiviral Research, vol. 73, no. 1, pp. 12–23, 2007. View at Publisher · View at Google Scholar · View at PubMed
  137. I. Lebars, T. Richard, C. Di Primo, and J.-J. Toulmé, “LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1,” Blood Cells, Molecules, and Diseases, vol. 38, no. 3, pp. 204–209, 2007. View at Publisher · View at Google Scholar · View at PubMed
  138. J. S. Eisen and J. C. Smith, “Controlling morpholino experiments: don't stop making antisense,” Development, vol. 135, no. 10, pp. 1735–1743, 2008. View at Publisher · View at Google Scholar · View at PubMed